<DOC>
	<DOC>NCT00956371</DOC>
	<brief_summary>The primary objective of this study is to evaluate the safety and tolerability of ONO-7746 in healthy adult subjects. The secondary objectives are to characterize the pharmacokinetic and pharmacodynamic profiles of ONO-7746.</brief_summary>
	<brief_title>ONO-7746 Study in Healthy Adult Subjects</brief_title>
	<detailed_description />
	<criteria>Healthy nonsmoking male or female subjects (1855 years inclusive) Body mass index (BMI) of 1935 kg/mÂ² (inclusive) For females: postmenopausal, nonlactating and nonpregnant History or presence of clinically significant disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>ONO-7746</keyword>
	<keyword>Healthy adult subjects</keyword>
</DOC>